Overview
The company develops lightweight, controllable AI protein design models to reduce the difficulty, duration and cost of developing new synthetic biology products and medicines. Drawing on the Shanghai National Center for Applied Mathematics’ Shanghai Jiao Tong University branch, Shanghai Jiao Tong University’s Institute of Natural Sciences, Chongqing Artificial Intelligence Research Institute and the AI Biomedicine Center at Zhangjiang Institute for Advanced Study, it promotes industry-academia-research integration and translation of laboratory results into industrial applications. Its team comes from universities including Tsinghua, Shanghai Jiao Tong and Johns Hopkins. It started business in 2023, has generated millions in revenue and signed multiple well-known industry leaders as customers.
Connected profiles
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
公司致力于开发轻量、可控的人工智能蛋白质设计模型。降低生物科技领域中开发新合成生物产品和新药的难度、周期和成本，公司依托于上海国家应用数学中心（上海交通大学分中心）、上海交通大学自然科学研究院、重庆人工智能研究院和张江高等研究院人工智能生物医药中心，推动产学研一体化，促进实验室成果向工业应用的转化。公司团队来自于清华，交大，约翰霍普金斯大学等高校。2023年开展业务，已有数百万收入，签约多家知名行业头部企业。